Health
U.S. FDA’s Hahn plans ‘significant’ work with AstraZeneca in COVID-19 trial inquiry – Reuters
The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc’s U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do “very significant work” with the company as it conducts its investigation after an illness in…
By Reuters Staff
(Reuters) – The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plcs U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do very significant work with the company as it conducts its investigation after an illness in a participant in Britain.
Were here to protect the American public and were going to do very significant work with the company to figure out if theres a significant safety issue or not, FDA Commissioner Stephen H…
-
Noosa News23 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News22 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News24 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General23 hours agoInternal Revenue Service starts cutting 20,000 workers